Breast Cancer 2025 | Dublin | Ireland | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

- Breast Cancer 2025

Welcome Message

It is with immense pleasure and enthusiasm that we warmly welcome you to the 12th European Congress on Breast Cancer, Women’s Health, and Therapeutics. This much-anticipated event will take place in the vibrant city of Dublin, Ireland from Jun 24-25, 2025.

The theme of this year’s conference is “Together for a Future Without Breast Cancer.” Breast Cancer 2025 serves as a unique platform for connecting with esteemed professionals from around the globe and offers an excellent opportunity to advance your career. The conference program features plenary sessions, poster presentations, keynote speeches, special sessions, and more.

Our aim is to unite research scholars, academic experts, medical practitioners, clinical healthcare professionals, and emerging researchers to foster academic excellence. The scientific sessions will explore key topics, including male breast cancer, gynecology and obstetrics, innovative clinical trials, and breast cancer surgery. This event provides a dynamic space for discussion, offering valuable insights into innovations, treatments, and advancements in the field.

We are thrilled to welcome you to Breast Cancer 2025 and are excited to host this gathering in Dublin, Ireland. Together, let’s contribute to improving women’s health and making a lasting impact on scientific progress. We look forward to your participation and collaboration.

Warmest Regard
Lenora Warren | Program Manager
Breast Cancer 2025

About Conference

Our conference covers a broad spectrum of key topics, offering in-depth insights into breast cancer. This disease can affect a woman's overall health, leading to issues such as immune system challenges, cell degeneration, various stages of malignancy, and even a complete loss of health and vitality. The event will highlight the pioneering researchers and their groundbreaking projects in the field. Leading figures from the scientific community, who have made notable contributions to cancer and breast cancer research, will participate in the conference. Conference Goals: To unite scientists, researchers, physicians, academics, and healthcare professionals in one place to advance scientific knowledge. To discuss the latest developments and trends in breast cancer research. To explore the challenges and opportunities in advancing medicines for women’s health. To provide a platform for speakers and attendees to exchange innovative ideas. To identify strategies to drive research forward in breast cancer, women’s health, and therapeutic interventions in the near future. We extend our heartfelt thanks to all the distinguished keynote speakers, presenters, conference participants, students, organizations, media partners, exhibitors, and guests for making Breast Cancer 2021 a remarkable and successful event. Past Conference Summary: The 10th European Congress on Breast Cancer, Women's Health, and Therapeutics was held as a webinar on December 10, 2021, under the theme "Emerging Trends and Advances in Breast Cancer and Women's Health Research." This event was one of Allied Academies’ most engaging and successful gatherings of 2021, thanks to the active participation of the organizing committee, researchers, scientists, corporate representatives, and academic communities. The conference was marked by the participation of brilliant young academics, industry leaders, and talented students from over 18 countries, driving the event’s success. Key highlights included discussions on the latest research on retroviruses. The conference was structured around various sessions, covering important scientific topics such as: Breast Cancer Types of Breast Cancer Surgical Approaches for Breast Cancer Treatments for Breast Cancer Rehabilitation for Breast Cancer Survivors We would like to acknowledge the efforts of the organizing committee, keynote speakers, and all contributors who helped make the event a success. We are grateful for the time and dedication of all presenters and wish them continued success in their future endeavors. With the success of Breast Cancer 2021, Allied Academies is excited to announce the upcoming 11th World Congress on Breast Cancer, Women’s Health, and Therapeutics, which will be held from April 27-29, 2023 in Amsterdam, Netherlands.

Sessions

Session 1: Breast Cancer

In addition to improving patient satisfaction with their care, healthcare professionals around the world are striving to create better methods for addressing, preventing, diagnosing, and treating breast cancer. This Breast Cancer conference covers general information about breast cancer and its risk factors. General information regarding breast cancer in 2023 and its risk factors is covered throughout the workshop. This topic includes the several kinds of study that are being conducted on the severity of breast cancer, its risk factors, its effects on women's health, and the treatments and measures that should be done before things get worse.

Track 1.1: Early Detection and Screening

Track 1.2: Advances in Breast Cancer Treatment

Track 1.3: Breast Cancer Genetics and Risk Factors

Track 1.4: Breast Cancer Survivorship and Support

Track 1.5: Innovations in Breast Cancer Research

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 2: Screening of Breast Cancer

The goal of breast cancer screening tests in 2023 is to find malignancies before they become harmful. You must become knowledgeable about screening tests and diagnostic tools for breast disease in order to prevent it in its early stages. Early identification is the use of a technique or test that allows the analysis of breast development earlier than would normally be possible. There are multiple methods for detecting breast cancer. While some tests are more invasive yet yield more information, others are necessary. Regardless, early detection of this bosom growth disease is crucial. Mammography is one of the most popular ways to screen for breast cancer.

Track 2.1: Mammography Techniques
Track 2.2: Breast MRI and Ultrasound
Track 2.3: Genetic Screening in Breast Cancer
Track 2.4: AI in Breast Cancer Detection
Track 2.5: Screening Guidelines and Protocols

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 3: Surgery for Breast Cancer

Surgery has historically been the most popular method of removing a cancerous tumor. It is the most used method of cancer treatment. Testing may occasionally be postponed until after mastectomy or breast-conserving surgery (BCS), which eliminates the entire cancer. Breast cancer surgery techniques for 2023 include lumpectomy, partial mastectomy, double mastectomy, and segmental mastectomy (breast-conserving surgery). Depending on how quickly the cancer is spreading, the type of surgery is chosen. A mastectomy eliminates the entire breast while stopping the cancer from spreading to other organs, while breast-conserving surgery removes the cancer while preserving the breast. Removing nearby lymph nodes is also a popular surgical practice.

Track 3.1: Breast-Conserving Surgery
Track 3.2: Mastectomy Techniques
Track 3.3: Reconstructive Surgery Options
Track 3.4: Oncoplastic Surgery Innovations
Track 3.5: Surgical Management of Metastatic Breast Cancer

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 4: Breast Reconstruction

The process of redesigning the breast, usually in breast cancer survivors, is known as breast reconstruction. The women's breasts are completely removed during the mastectomy. It might affect the women's way of life and emotional well-being. This lesson covers the importance of breast surgery in 2023 as well as the lifestyles of the patients after treatment.

Track 4.1: Implant-Based Reconstruction
Track 4.2: Autologous Tissue Reconstruction
Track 4.3: Advances in Oncoplastic Reconstruction
Track 4.4: Managing Complications in Reconstruction
Track 4.5: Psychosocial Aspects of Breast Reconstruction

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 5: Breast disease

Most breast lumps are benign, meaning they are not malignant. Both men and women can have benign (noncancerous) fibrocystic breasts. This condition is known as "Benign Breast Disease". These breast changes may increase your risk of developing breast cancer in the future, even though they are not harmful or life-threatening.

Track 5.1: Benign Breast Disorders
Track 5.2: Inflammatory Breast Diseases
Track 5.3: Fibrocystic Breast Changes
Track 5.4: High-Risk Breast Lesions
Track 5.5: Rare Breast Diseases

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 6: Breast Cancer Resuscitation

It could seem like a battle for survival to recover from cancer treatment. The truth is that, especially for women with breast cancer, there will be new choices to make and possibly even new opportunities in life following treatment. In order to prevent breast cancer from recurring, there are a number of strategies that should be used in daily life, such as making dietary changes and exercising frequently. Bone density may decrease as a result of a drop in estrogen levels. Exercise can be utilized to halt the cycles of breast development and to assist thicken bones.

Track 6.1: Management of Advanced-Stage Breast Cancer
Track 6.2: Overcoming Treatment Resistance
Track 6.3: Rehabilitative Care for Breast Cancer Survivors
Track 6.4: Revival of Immune Response in Breast Cancer
Track 6.5: Enhancing Quality of Life Post-Treatment

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 7: Male Breast Cancer

A male chest disease is similar to breast cancer 2023 in women in that it refers to uncontrolled growth with the potential for some of the cells in this chest tissue to disseminate. Eventually, they grow so unique and straightforward that they are called cancer cells. The chest tissue of both young men and women has tubular structures called channels. Although breast cancer is more common in women, it can also strike men. Males also have a small number of breast tissues in the chest region that are not functional. The American Cancer Society reports that, on average, 480 men lose their lives to breast cancer every year. The condition affects about 2550 males.

Track 7.1: Epidemiology of Male Breast Cancer
Track 7.2: Genetic Risk Factors in Male Breast Cancer
Track 7.3: Diagnostic Challenges in Male Breast Cancer
Track 7.4: Treatment Strategies for Male Breast Cancer
Track 7.5: Psychosocial Impact on Male Breast Cancer Patients

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 8: Treatment for Breast Cancer

A person's degree of health and well-being depends on their underlying medical condition, and there are two treatment options for breast cancer in 2023: local and systemic. Depending on the circumstance, several therapeutic modalities are employed. When the cancer is localized, surgery is the mainstay of treatment for bosom disease. Chemotherapy for ER-positive tumors and adjuvant hormonal therapy (with tamoxifen or an aromatase inhibitor) come next. With each risk group following distinct treatment guidelines, a multidisciplinary team works to manage breast cancer in compliance with national and international legislation. Therapeutic outcomes include hormone therapy, chemotherapy, radiation therapy, and invulnerable treatments.

Track 8.1: Chemotherapy and Targeted Therapies
Track 8.2: Hormonal Therapy for Breast Cancer
Track 8.3: Immunotherapy Advancements
Track 8.4: Radiation Therapy Innovations
Track 8.5: Personalized Medicine in Breast Cancer Treatment

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 9: Breast Cancer Therapies

Focused therapies are one cutting-edge method of treating breast cancer. Researchers at Mass General are demonstrating the effectiveness of novel anticancer treatments in breast development through a few clinical trials. A class of medications known as PI3 kinases (PI3K) regulates the mTOR protein, which is the target of the targeted therapy everolimus. In healthy cells, mTOR is involved in many different activities, such as cell proliferation and protein fusion. Instead of having a mastectomy, many women choose to have breast-preserving surgery, which involves removing only the cancer and a tiny amount of surrounding tissue.

Track 9.1: Neoadjuvant and Adjuvant Therapies
Track 9.2: Antibody-Drug Conjugates in Breast Cancer
Track 9.3: Emerging Targeted Therapy Approaches
Track 9.4: Combination Therapy Strategies
Track 9.5: Palliative Therapies for Advanced Breast Cancer

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 10: Clinical trials in Breast Cancer

Pre-clinical research on mice are conducted to detect any adverse side effects, and clinical trials for Breast Cancer 2023 have been found to be voluntary; patients participate in the trials as part of their treatment regimens. Participation in a number of clinical research on breast cancer is open to the public. Pre-clinical research helps determine whether the suggested treatment plan is safe. Clinical studies can address the negative effects of all breast cancer medications. Research on breast cancer may potentially benefit from clinical trials. Research on breast cancer is currently being conducted at the genetic level. Medical experts claim that faulty genes have a detrimental effect on the breast.

Track 10.1: Innovations in Breast Cancer Drug Trials
Track 10.2: Immunotherapy Clinical Trials
Track 10.3: Patient Recruitment and Challenges in Trials
Track 10.4: Biomarkers in Breast Cancer Clinical Studies
Track 10.5: Outcomes of Ongoing and Recent Trials

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 11: Chemotherapy for Breast Cancer

The body's malignant cells can be prevented, inhibited, or killed using chemotherapy. Both normal and malignant cells may occasionally be eradicated during the course of the therapy. Breast cancer cannot be treated with more than two drug combinations. Although it is not always required, doctors would prefer chemotherapy if the patient had a more aggressive tumor. After this session, the entire course of chemotherapy for breast cancer 2023 has been administered.

Track 11.1: Standard Chemotherapy Regimens
Track 11.2: Advances in Combination Chemotherapy
Track 11.3: Managing Chemotherapy Side Effects
Track 11.4: Chemotherapy in Triple-Negative Breast Cancer
Track 11.5: Optimizing Dose-Dense Chemotherapy

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 12: Types of Breast Cancer

The lobules, channels, and even the tissue in the center of the chest are among the places where breast cancer can start. There, you can read more about the uninvolved, prominent, discontinuous, and metastatic chest cancers, as well as the obvious subtypes of breast cancer, such as the benign or sub-nuclear subtypes. Likewise, you can read about chest cancer in men. The following are the essential phrases: Invasive Ductal Carcinoma (IDC), breast tubular carcinoma, ductal carcinoma in situ (DCIS), breast mucinous carcinoma, and breast medullary carcinoma are examples of IDC types. IDC kinds include cribriform breast cancer, papillary breast cancer, and others. Lobular cancer that invades (ILC)

Track 12.1: Invasive Ductal Carcinoma (IDC)
Track 12.2: Invasive Lobular Carcinoma (ILC)
Track 12.3: Triple-Negative Breast Cancer
Track 12.4: HER2-Positive Breast Cancer
Track 12.5: Rare and Uncommon Breast Cancer Types

Related Associations:

Associated Journals:

Associated Societies:

Session 13: Breast Cancer metastatic

The process by which cancer spreads is referred to as metastasis. Metastasis is the process by which cancer cells leave the original breast tumor and travel to other parts of the body. Breast cancer can spread to other parts of the body months or even years after the initial diagnosis and treatment. This is known as a metastatic or distant recurrence. More than 30% of women with early-stage breast cancer suffer from the metastatic disease. Because there are so few occurrences of male breast cancer, it is unknown how often men are also diagnosed with metastatic breast cancer. This suggests that by the time the breast cancer is first detected, it has spread to another part of the body.

Track 13.1: Mechanisms of Breast Cancer Metastasis
Track 13.2: Targeted Therapies for Metastatic Breast Cancer
Track 13.3: Bone Metastasis in Breast Cancer
Track 13.4: Brain Metastasis in Breast Cancer
Track 13.5: Managing Pain and Symptoms in Metastatic Breast Cancer

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 14: Genetics of Breast Cancer:

The 5–10% death rate is believed to be caused in part by genes linked to cancer and their inheritance. Mothers who were diagnosed with breast cancer before the age of 50 may be genetically impacted for generations, and survivors are more likely to pass the gene on to their offspring. Two genes, BRCA1 and BRCA2, are implicated in the genetics of breast cancer. In adults over 80, the risk and mortality rates for breast cancer range from 4 to 5%. Knowing the genes is essential when it comes to the genetic variables that cause breast cancer.

Track 14.1: Inherited Genetic Mutations and Risk
Track 14.2: BRCA1 and BRCA2 Gene Mutations
Track 14.3: Genetic Testing and Counseling in Breast Cancer
Track 14.4: Epigenetics and Breast Cancer Development
Track 14.5: The Role of Genetic Research in Personalized Treatment

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 15: Breast Cancer mastectomy

The surgical removal of all or part of your breast tissue is known as a mastectomy. It serves as both a prophylactic and a therapy for breast cancer in 2023. Surgery is a long-term part of breast cancer treatment. If you have a high risk of breast cancer, your doctor can recommend a preventive mastectomy to help stop the disease from spreading in the future. Your breast tissue can be removed entirely or in part with a variety of mastectomies.

Track 15.1: Types of Mastectomy Procedures
Track 15.2: Skin-Sparing Mastectomy Techniques
Track 15.3: Nipple-Sparing Mastectomy
Track 15.4: Post-Mastectomy Reconstruction Options
Track 15.5: Psychological Impact of Mastectomy

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 16: Mental health

There is a significant connection between mental and physical wellness. Changes in lifestyle, hormone biology, diseases, disorders, and psychological factors all have an impact on one's mental health. The session includes dementia, Alzheimer's disease, and other well-known mental diseases associated with physiological and environmental factors.

Track 16.1: Psychological Impact of Breast Cancer Diagnosis
Track 16.2: Coping Strategies for Patients and Families
Track 16.3: Mental Health Support for Breast Cancer Survivors
Track 16.4: Managing Anxiety and Depression in Breast Cancer
Track 16.5: Role of Therapy and Counseling in Cancer Care

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 17: Breast Cancer during pregnancy

Your breasts change during pregnancy to get ready for nursing. Breast tissue becomes denser. This may make it more challenging to identify breast cancer-related alterations. The most common sign of breast cancer is a lump. If a change continues after two to four weeks, let your doctor know. Research indicates that once pregnant women start exhibiting breast symptoms, there may be a delay in diagnosis. According to medical professionals, your treatment should be as similar as feasible to that of a non-pregnant individual. Additionally, therapy shouldn't be delayed whenever possible.

Track 17.1: Diagnosis and Challenges of Breast Cancer in Pregnancy
Track 17.2: Treatment Options for Pregnant Breast Cancer Patients
Track 17.3: Surgical Considerations in Pregnancy-Related Breast Cancer
Track 17.4: Chemotherapy and Radiation Therapy During Pregnancy
Track 17.5: Psychological and Emotional Impact of Breast Cancer in Pregnancy

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 18: Gynecology in Women's Health

The session will cover gynecological health, breast cancer, and obstetrics. A woman's reproductive system functioning properly is linked to her gynecological health. Gynecological health is impacted by a number of factors, including menstruation, birth control pills, endometriosis, HPV, ovarian cancer, cervical cancer, and menopause. Pregnancy concerns and the postpartum phase are covered in obstetrics. The Gynecology and Obstetrics area encourages research articles and related sessions. The session is a high point and important.

Track 18.1: Advances in Gynecological Cancer Detection
Track 18.2: Menstrual Health and Disorders
Track 18.3: Hormonal Imbalances and Treatments
Track 18.4: Reproductive Health and Fertility Preservation
Track 18.5: Preventive Care and Women's Health Screenings

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 19: Researches in Breast Cancer

All facets of breast cancer and cancer research, including causes, prevention, and treatment, are being studied; in the upcoming years, new therapeutic modalities will be available. 2023 Breast Cancer Since research and trials have been conducted on women and have led to more innovative treatment options, they have always been successful. Scientists are still trying to determine, identify, or remove the tumor as quickly and easily as feasible. The first step involved teaching all women how to use certain techniques to determine if they had a tumor, which led to a major shift in the way breast cancer was treated.

Track 19.1: Breakthroughs in Breast Cancer Genetics
Track 19.2: Targeted Therapy and Immunotherapy Research
Track 19.3: Clinical Trials and Their Impact
Track 19.4: Personalized Medicine in Breast Cancer
Track 19.5: Advances in Early Detection Technologies

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 20: Women Oncology

Any tumor's main defense against its spread is growth, which triggers an immunological reaction. The growth of the immune system and the tumor's progression are related in the case of Breast Cancer 2023. Tumors contain a range of safe cells that can help identify the progression of breast growth. Treatments for breast cancer can change these resistant cells if the disease progresses. B lymphocytes secrete immunoglobulin that is specific for an antigen and may have anticancer properties. The bone marrow of patients with breast cancer has more B cells than the normal individual, which may be a significant consideration in breast cancer treatment.

Track 20.1: Gynecological Cancers in Women
Track 20.2: Advances in Breast Cancer Treatment for Women
Track 20.3: Ovarian Cancer: Early Detection and Treatment
Track 20.4: Cervical Cancer Prevention and Screening
Track 20.5: Emotional and Psychological Support for Women with Cancer

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies: